Evidence map›Paper›PMID 35312721›Full record

ArticlePloS one2022

An efficient algorithm calculating common solvent accessible volume.

In Jung Kim, Hyuntae Na

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

In Jung KimDepartment of Computer Science, Penn State Harrisburg, Middletown, Pennsylvania, United States of America.ORCID 0000-0001-5797-8235
Hyuntae NaDepartment of Computer Science, Penn State Harrisburg, Middletown, Pennsylvania, United States of America.ORCID 0000-0002-9793-7363

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The solvent accessible surface area and the solvent accessible volume are measurements commonly used in implicit solvent models to include the effect of forces exerted by solvents on the protein surfaces (or the atoms on protein surfaces). The two measurements have limitations in describing interactions between proteins (or proteins' atoms) mediated/bridged by solvents. This is because describing the interactions between proteins should be able to capture the chain of protein-solvent-protein interactions while the solvent accessible surface area or the solvent accessible volume can capture only protein-solvent interactions. If we represent the solvent as a continuous medium, we can consider an atom of a protein can effectively interact with the solvent within a certain distance from its surface (or its own solvent-interacting sphere). In this case, the protein-solvent-protein interactions can be measured by the amount of solvent interacting with two proteins' atoms at the same time (or the volume shared by the two atoms' solvent-interacting spheres excluding the volumes occupied by proteins' atoms). We call the shared volume as the common solvent accessible volume (CSAV); there has been no method developed to determine the CSAV. In this work, we propose a new sweep-line-based method that efficiently calculates the common solvent accessible volume. The performance and accuracy of the proposed sweep-line-based method are compared with those of the naïve voxel-based method. The proposed method takes log-linear time to the number of atoms involved in a CSAV calculation and linear time to the resolution. Our results, tested with 52 protein structures of various sizes, show that the proposed sweep-line-based method is superior to the voxel-based method in both computational efficiency and accuracy.

Indexed as

AlgorithmsProteinsSolventsProteinsSolvents

Identifiers

PMID35312721
PMCPMC8936456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.